Development of a disease conceptual model of patient experience with metastatic colorectal cancer: identification of the most salient symptoms and impacts.

Author:

Guillemin Isabelle1,Darpelly Mahesh1,Wong Brendon2,Ingelgård Anders2,Griebsch Ingolf2

Affiliation:

1. IQVIA

2. Boehringer Ingelheim International GmbH

Abstract

Abstract Purpose. Patients with metastatic colorectal cancer (mCRC) experience multiple symptoms and impacts affecting their health-related quality of life. However, there is limited data on self-reported experience of the most relevant and bothersome aspects of patients living with mCRC.Methods. Semi-structured interviews were conducted in patients with mCRC to identify and understand the signs, symptoms and impacts experienced. Patients were also asked to rate the level of bothersomeness for each concept reported on a scale ranging from 0 (“not bothersome at all”) to 10 (“extremely bothersome”). Verbatim transcripts were analysed following a thematic analysis approach. The most salient concepts were identified (i.e., reported by >50% of patients with a bothersome rating ≥5 out of 10).Results. Twenty-five patients (United States; age: 26 to 72 years old) were interviewed. Patients reported 58 signs and symptoms, amongst which 8 were considered salient: fatigue, nausea, neuropathy, diarrhoea, loss of appetite, constipation, weight loss, and abdominal pain; 35 impacts were identified and 7 were considered salient: reduced ability to work, interference with daily activities, impact on cognitive functioning, financial impact, sleep changes, impact on social life and walking difficulties. The concepts identified helped refine a literature-based disease conceptual model of patient experience with mCRC.Conclusions. The interviews provided insights into the most bothersome and salient signs, symptoms and impacts affecting the HRQoL of patients living with mCRC.Implications for cancer survivors. There is a need to improve clinical strategies for future clinical development and inform clinical practice decision-making for mCRC survivors.

Publisher

Research Square Platform LLC

Reference17 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray F;CA Cancer J Clin,2018

2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019 Jan;69(1):7–34.

3. A Systematic Literature Review and Meta-Analysis Describing the Prevalence of KRAS, NRAS, and BRAF Gene Mutations in Metastatic Colorectal Cancer;Levin-Sparenberg E;Gastroenterol Res,2020

4. National Cancer Institute. Surveillance, Epidemiology, and End Results Program. SEER. 2021. https://seer.cancer.gov/index.html. Accessed 19 Feb 2021

5. Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review;Biller LH;JAMA,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3